1h Free Analyst Time
The publisher has been monitoring the in situ hybridization (ISH) market and it is poised to grow by $ 475.05 mn during 2021-2025, progressing at a CAGR of about 7% during the forecast period. The report on in situ hybridization (ISH) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing demand for companion diagnostic tests and product launches.
The in situ hybridization (ISH) market analysis includes technology segment, end-user segment, and geographic landscape.
The in situ hybridization (ISH) market is segmented as below:
By Technology
- FISH
- CISH
By End-user
- Molecular diagnostic laboratories
- Pharmaceutical and biotechnological companies
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the growing incidence and prevalence of cancer as one of the prime reasons driving the in situ hybridization (ISH) market growth during the next few years.
The report on in situ hybridization (ISH) market covers the following areas:
- In situ hybridization (ISH) market sizing
- In situ hybridization (ISH) market forecast
- In situ hybridization (ISH) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in situ hybridization (ISH) market vendors that include Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the in situ hybridization (ISH) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Technology
Market Segmentation by End-user
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global in situ hybridization (ISH) market: Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the growing incidence and prevalence of cancer.'
According to the report, one of the major drivers for this market is the increasing demand for companion diagnostic tests.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Bio-Techne Corp.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- NeoGenomics Laboratories Inc.
- PerkinElmer Inc.
- QIAGEN NV
- Thermo Fisher Scientific Inc.